Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Dec 21, 2011; 17(47): 5166-5171
Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5166
Published online Dec 21, 2011. doi: 10.3748/wjg.v17.i47.5166
Figure 2 Fecal calprotectin levels at baseline, and 2 and 6 wk after introduction of infliximab therapy showing the individual variation in children with inflammatory bowel disease.
- Citation: Hämäläinen A, Sipponen T, Kolho KL. Infliximab in pediatric inflammatory bowel disease rapidly decreases fecal calprotectin levels. World J Gastroenterol 2011; 17(47): 5166-5171
- URL: https://www.wjgnet.com/1007-9327/full/v17/i47/5166.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i47.5166